55

Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).

Andersson SO, Andren O, Lyth J, Stark JR, Henriksson M, Adami HO, Carlsson P, Johansson JE.

Scand J Urol Nephrol. 2011

SPCG-4

Abstract

54

Inguinal hernia after radical prostatectomy for prostate cancer: results from a randomized setting and a nonrandomized setting

Stranne J, Johansson E, Nilsson A, Bill-Axelsson A, Carlsson S, Holmberg L, Johansson JE, Nyberg T, Ruutu M, Wiklund NP, Steineck G

Eur Urol. 2010

SPCG-4

Abstract

53

Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer

Steinsvik EA, Fosså SD, Axcrona K, Fransson P, Widmark A, Dahl AA

J Urol. 2010

SPCG-7/FUO3

Abstract

52

Validation of the intestinal part of the prostate cancer questionnaire «QUFW94»: psychometric properties, responsiveness, and content validity

Reidunsdatter RJ, Lund JA, Fransson P, Widmark A, Fosså SD, Kaasa S

Int J Radiat Oncol Biol Phys. 2010

SPCG-7/FUO3

Abstract

51

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A

Lancet Oncol. 2009

SPCG-7/FUO3

Abstract

50

Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: The randomized Scandinavian Prostate Cancer Group study number 4

Johansson E, Bill-Axelson A, Holmberg L, Onelöv E, Johansson J-E, Steineck G

Eur Urol. 2009

SPCG-4

Abstract

49

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD

Lancet. 2009

SPCG-7/FUO3

Abstract

48

PSA kinetics improved prediction of survival in metastatic hormone-refractory prostate cancer.

Robinson D, Sandblom G, Johansson R, Garmo H, Aus G, Hedlund PO, Varenhorst E; Scandinavian Prostate Cancer Group.

Urology. 2008

SPCG-5

Abstract

47

Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial

Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson JE

J Natl Cancer Inst. 2008

SPCG-4

Abstract

46

Prediction of Survival of Metastatic Prostate Cancer Based on Early Serial Measurements of Prostate Specific Antigen and Alkaline Phosphatase.

Robinson D, Sandblom G, Johansson R, Garmo H, Stattin P, Mommsen S, Varenhorst, E and the candinavian Prostate Cancer Group (SPCG)-5.

J Urol. 2008

SPCG-5

Abstract